StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.02 (-0.20%)

Close on Nov 20, 2026Market cap $140.15MP/E –Yield –

Drugs Made In America Acquisition II shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

No shares outstanding figures for Drugs Made In America Acquisition II

Drugs Made In America Acquisition II has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Drugs Made In America Acquisition II figures

See a number that looks wrong?